Invizyne Technologies Inc

Chart & Performance

D1W1MN

P/E

—

P/S

—

EPS

—

Div Yield, %

—

Shrs. gr., 5y

—

Rev. gr., 5y

Revenues

Net income

-9m

L+56.26%

CFO

-7m

L-23.56%

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Invizyne Technologies Inc. is an American synthetic biochemical company that has developed SimplePath, an innovative platform. This technology is designed to synthesize a diverse range of chemicals, including vital substances like pharmaceuticals, fuels, and advanced materials, as well as food additives and entirely novel compounds. At its core, SimplePath is composed of specialized modules, each integrating one or more enzymes that collaboratively execute defined biocatalytic conversions. Established in 2014, Invizyne Technologies' operations are headquartered in Monrovia, California.

URL

https://www.invizyne.com/

IPO date

Nov 13, 2024

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title USD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY
Title USD in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT